Joseph Wagner

Nessuna posizione attualmente

59 anni

Health Technology

Consumer Services

Profilo

Joseph P.
Wagner served as Chief Executive Officer at Insight Molecular Diagnostics, Inc. Served as President, Chief Executive Officer & Director at BriaCell Therapeutics Corp.
from 2015 to 2016.
Served as Executive Director at University of California Drug Discovery Consortium.
Served as Vice President-Cellular Therapy at Neuronyx, Inc. Served as President at Cell Targeting, Inc. Served as Chief Scientific Officer at Notable Labs Ltd. from 2020 to 2024.
Education includes undergraduate studies at Rochester Christian University and a doctorate from Duke University School of Medicine.

Precedenti posizioni note di Joseph Wagner

Società	Posizione	Fine
BRIACELL THERAPEUTICS CORP.	Amministratore Delegato	24/03/2016
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Corporate Officer/Principal	13/10/2009
University of California Drug Discovery Consortium	Direttore/Membro del Consiglio	-
Cell Targeting, Inc. Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions	Presidente	-

Vedi nel dettaglio l'esperienza di Joseph Wagner

Formazione di Joseph Wagner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Joseph Wagner

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	7
Rochester Christian University Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Health Technology
Cell Targeting, Inc. Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions	Health Technology
OncoCyte Corp. OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer	Health Technology
Duke University School of Medicine Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer	Health Technology
University of California Drug Discovery Consortium